Company & Sponsor Intelligence
New York State Psychiatric Institute
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials18
Recruiting1
Completed14
Countries2
Therapeutic footprint
adhdanxietyautismdepressioneating_disordersneurodevelopmental_otherother_psychiatryschizophreniasubstance_use
Indexed studies
NCT02978599Clinical Trial of AVL-3288 in Schizophrenia Patients
schizophrenia · United StatesPHASE1
schizophrenia · United StatesPHASE1
NCT01467999Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence
substance_use · United StatesPHASE1
substance_use · United StatesPHASE1
NCT0390261318F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder
depression · United StatesPHASE4
depression · United StatesPHASE4
NCT03036371Pilot Study of the Impact of Exercise on Hippocampal Function
anxiety · United StatesNA
anxiety · United StatesNA
NCT00881699Testing an HIV Prevention Intervention for Psychiatric Patients in Brazil
other_psychiatry · BrazilPHASE3
other_psychiatry · BrazilPHASE3
NCT01377610Improved Strategies for Outpatient Opioid Detoxification
other_psychiatry · United StatesPHASE1
other_psychiatry · United StatesPHASE1
NCT03711318Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
other_psychiatry · United StatesPHASE3
other_psychiatry · United StatesPHASE3
NCT00429221Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder
adhd · NA
adhd · NA
NCT01519557Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders
schizophrenia · United StatesEARLY_PHASE1
schizophrenia · United StatesEARLY_PHASE1
NCT00304187Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
eating_disorders · United StatesPHASE2
eating_disorders · United StatesPHASE2
NCT00257725Long-Duration Stimulant Treatment Study of ADHD in Young Children
adhd · United StatesPHASE4
adhd · United StatesPHASE4
NCT02932215Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder
substance_use · United StatesPHASE1
substance_use · United StatesPHASE1
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →